BR0012318A - Compostos semelhantes a amino ceramida e métodos terapêuticos de uso - Google Patents

Compostos semelhantes a amino ceramida e métodos terapêuticos de uso

Info

Publication number
BR0012318A
BR0012318A BR0012318-8A BR0012318A BR0012318A BR 0012318 A BR0012318 A BR 0012318A BR 0012318 A BR0012318 A BR 0012318A BR 0012318 A BR0012318 A BR 0012318A
Authority
BR
Brazil
Prior art keywords
compounds
amino
ceramide
therapeutic methods
glccer
Prior art date
Application number
BR0012318-8A
Other languages
English (en)
Inventor
James A Shayman
Norman S Radin
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/350,768 external-priority patent/US6255336B1/en
Application filed by Univ Michigan filed Critical Univ Michigan
Priority claimed from PCT/US2000/018935 external-priority patent/WO2001004108A1/en
Publication of BR0012318A publication Critical patent/BR0012318A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSTOS SEMELHANTES A AMINO CERAMIDA E MéTODOS TERAPêUTICOS DE USO". São fornecidos novos compostos semelhantes a amino ceramida ( 1 ) que inibem a formação de glicosil ceramida ( GlcCer ) pela inibição da enzima GlcCer sintase, desta forma diminuindo o nível de glicoesfingolipídeos. Os compostos da presente invenção possuem atividade de inibição de GlcCer sintase aumentada e são, desta forma, altamente úteis em métodos terapêuticos para tratamento de várias condições e doenças associadas com níveis alterados de glicoesfingolipídeos.
BR0012318-8A 1999-07-09 2000-07-07 Compostos semelhantes a amino ceramida e métodos terapêuticos de uso BR0012318A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/350,768 US6255336B1 (en) 1995-09-20 1999-07-09 Amino ceramide-like compounds and therapeutic methods of use
PCT/US2000/018935 WO2001004108A1 (en) 1999-07-09 2000-07-07 Amino ceramide-like compounds and therapeutic methods of use
CA002454453A CA2454453A1 (en) 2000-07-07 2003-12-24 Amino ceramide-like compounds and therapeutic methods of use

Publications (1)

Publication Number Publication Date
BR0012318A true BR0012318A (pt) 2002-05-28

Family

ID=56290039

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012318-8A BR0012318A (pt) 1999-07-09 2000-07-07 Compostos semelhantes a amino ceramida e métodos terapêuticos de uso

Country Status (6)

Country Link
EP (1) EP1196406A1 (pt)
JP (1) JP2003521479A (pt)
AU (1) AU774960B2 (pt)
BR (1) BR0012318A (pt)
CA (1) CA2378600A1 (pt)
MX (1) MXPA02000296A (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8003617B2 (en) * 2004-11-10 2011-08-23 Genzyme Corporation Methods of treating diabetes mellitus
ES2660690T3 (es) * 2007-10-05 2018-03-23 Genzyme Corporation Método para tratar poliquistosis renales con derivados de ceramida
EP3078373A1 (en) * 2008-10-03 2016-10-12 Genzyme Corporation 2-acylaminopropanol-type glucosylceramide synthase inhibitor
WO2011066352A1 (en) * 2009-11-27 2011-06-03 Genzyme Corporation An amorphous and a crystalline form of genz 112638 hemitartrat as inhibitor of glucosylceramide synthase
CN116239513B (zh) * 2023-05-05 2023-08-18 天津凯莱英制药有限公司 Mmae关键中间体的制备方法、mmae的制备方法和抗体偶联药物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997010817A1 (en) * 1995-09-20 1997-03-27 The Regents Of The University Of Michigan Amino ceramide-like compounds and therapeutic methods of use

Also Published As

Publication number Publication date
CA2378600A1 (en) 2001-01-18
JP2003521479A (ja) 2003-07-15
AU5929600A (en) 2001-01-30
EP1196406A1 (en) 2002-04-17
MXPA02000296A (es) 2004-05-21
AU774960B2 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
BR0208373A (pt) Inibidores da tirosina cinase
BR0206400A (pt) Compostos de amino ceramidas e seus usos em métodos terapêuticos
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
BRPI0410927A (pt) métodos terapêuticos e profiláticos para distúrbios neuromusculares
BR9912501A (pt) Tratamento de distúrbios hiperproliferativos
NO981944L (no) Lipopolyaminer som transfeksjonsmidler samt farmas÷ytisk anvendelse derav
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
EP1068870A4 (en) ANTITUMORAL AGENTS
BR0312217A (pt) Compostos, métodos de inibição da atividade/ativação de um receptor monoaminérgico e método de tratamento de condição doentia associada a um receptor de monoaminergético
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
DE69725293D1 (de) N-(2 oxoacetyl oder sulphonyl)-pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität
BRPI0007487B8 (pt) difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase
BRPI0312464B8 (pt) compostos inibidores de tirosina quinases, composições farmacêuticas compreendendo os mesmos, processos para fabricação e usos dos mesmos
BR0109703A (pt) Derivados de piperazina
BR0008958A (pt) Inibidores de reabsorção de monoamina para otratamento de distúrbios do snc
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
GB0222514D0 (en) Organic compounds
NO20024646L (no) Kombinasjonsterapier med vaskul¶r-skadende aktivitet
BR0315346A (pt) Método para o tratamento ou prevenção de sintomas de vasomotores em um paciente, formulação farmacêutica e utilização de inibidor de re-apreensão de norepinefrina em combinação com antagonista de 5-h2a
BR0012318A (pt) Compostos semelhantes a amino ceramida e métodos terapêuticos de uso
NO985676L (no) Forbindelser med colchicinstruktur, deres anvendelse som legemidler og blan
BR9807271A (pt) Tamoxifeno como terapia para reduzir diarréia induzida por cloridrato de irinotecano
BR0309055A (pt) Uso combinado de l-carnitina, acetil l-carnitina e propionil l-carnitina para o tratamento da oligoastenoteratospermia
SE9802538D0 (sv) New pharmaceutically active compounds

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009.